Apolipoprotein-b synthesis inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 405/14 (2006.01) A61K 31/495 (2006.01) C07D 405/12 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2203274

The present invention provides novel compounds of formula (I), the N-oxides, the stereochemically isomeric forms thereof, and the pharmaceutically acceptable acid addition salts thereof, wherein A and B taken together form a bivalent radical of formula: -N=CH- (a), -CH=N- (b), -CH2-CH2- (c), -CH=CH- (d), -C(=O)-CH2- (e), -CH2-C(=O)- (f); R1 is hydrogen, C1-6alkyl, or halo; R2 is hydrogen or halo; R3 is hydrogen; C1-8alkyl; C3-6cycloalkyl or C1-8 alkyl substituted with hydroxy, oxo, C3-6cycloalkyl or aryl. Het is five- or six membered optionally substituted heterocyclic ring. The use as a medicine, especially as a lipid lowering agent is disclosed as well as pharmaceutical compositions and processes for preparing compounds and compositions.

L'invention concerne les nouveaux composés de la formule (I), leurs N-oxydes, leurs formes stéréoisomères et leurs sels d'addition acides compatibles sur le plan pharmaceutique, dans laquelle A et B constituent ensemble un radical bivalent de la formule suivante: -N=CH- (a), -CH=N- (b), -CH¿2?-CH¿2?- (c), -CH=CH- (d), -C(=O)-CH¿2?- (e), -CH¿2?-C(=O)- (f); R?1¿ est de l'hydrogène, du C¿1-6? alkyle, ou du halo; R?2¿ de l'hydrogène ou du halo; R?3¿ de l'hydrogène; du C¿1-8? alkyle; du C¿3-6? cycloalkyle ou du C¿1-8? alkyle substitué par de l'hydroxy, de l'oxo, du C¿3-6? cycloalkyle ou de l'aryle. Het est un noyau hétérocyclique éventuellement substitué à 5 ou 6 chaînons. L'invention se rapporte à l'emploi de ces composés en médecine, en particulier en tant qu'hypolipémiants, ainsi qu'à des compositions et des procédés pharmaceutiques destinés à la préparation des composés et des compositions.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Apolipoprotein-b synthesis inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Apolipoprotein-b synthesis inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apolipoprotein-b synthesis inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1781976

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.